1. Home
  2. SKYQ vs HCWB Comparison

SKYQ vs HCWB Comparison

Compare SKYQ & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYQ
  • HCWB
  • Stock Information
  • Founded
  • SKYQ 2019
  • HCWB 2018
  • Country
  • SKYQ United States
  • HCWB United States
  • Employees
  • SKYQ N/A
  • HCWB N/A
  • Industry
  • SKYQ
  • HCWB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYQ
  • HCWB Health Care
  • Exchange
  • SKYQ NYSE
  • HCWB Nasdaq
  • Market Cap
  • SKYQ 26.1M
  • HCWB 26.6M
  • IPO Year
  • SKYQ N/A
  • HCWB 2021
  • Fundamental
  • Price
  • SKYQ $1.25
  • HCWB $0.37
  • Analyst Decision
  • SKYQ
  • HCWB
  • Analyst Count
  • SKYQ 0
  • HCWB 0
  • Target Price
  • SKYQ N/A
  • HCWB N/A
  • AVG Volume (30 Days)
  • SKYQ 301.4K
  • HCWB 274.4K
  • Earning Date
  • SKYQ 02-14-2025
  • HCWB 11-14-2024
  • Dividend Yield
  • SKYQ N/A
  • HCWB N/A
  • EPS Growth
  • SKYQ N/A
  • HCWB N/A
  • EPS
  • SKYQ N/A
  • HCWB N/A
  • Revenue
  • SKYQ $30,766,012.00
  • HCWB $3,495,990.00
  • Revenue This Year
  • SKYQ N/A
  • HCWB $229.19
  • Revenue Next Year
  • SKYQ N/A
  • HCWB N/A
  • P/E Ratio
  • SKYQ N/A
  • HCWB N/A
  • Revenue Growth
  • SKYQ N/A
  • HCWB 22.27
  • 52 Week Low
  • SKYQ $0.82
  • HCWB $0.28
  • 52 Week High
  • SKYQ $5.49
  • HCWB $2.52
  • Technical
  • Relative Strength Index (RSI)
  • SKYQ N/A
  • HCWB 43.55
  • Support Level
  • SKYQ N/A
  • HCWB $0.33
  • Resistance Level
  • SKYQ N/A
  • HCWB $0.38
  • Average True Range (ATR)
  • SKYQ 0.00
  • HCWB 0.05
  • MACD
  • SKYQ 0.00
  • HCWB -0.00
  • Stochastic Oscillator
  • SKYQ 0.00
  • HCWB 25.97

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: